Neurorecovery in post-stroke complications – from emerging clinical evidence to patient centered benefits

This webinar took place in April 2026 and focused on providing insights into the real-world clinical use of Cerebrolysin^® in the management of post-stroke complications.

The webinar addressed the ongoing clinical challenge that, despite advances in acute stroke care, a large proportion of survivors experience persistent functional impairments. Against this background, the discussion highlighted the potential role of adjunctive, pharmacologically active therapies such as Cerebrolysin^®, particularly when administered during the early recovery phase and in combination with structured rehabilitation.

Through a series of case-based presentations supported by clinical evidence and guideline inclusions, the speakers illustrated how Cerebrolysin^® improves functional outcomes across different domains of post-stroke recovery.

Please find all details in the report below.

The full recording of the webinar can be watched here.